Improved alpharetrovirus-based Gag.MS2 particles for efficient and transient delivery of CRISPR-Cas9 into target cells-Reference-Cited by-同舟云学术

Improved alpharetrovirus-based Gag.MS2 particles for efficient and transient delivery of CRISPR-Cas9 into target cells

Published:2022-03 Issue: Volume:27 Page:810-823
ISSN:2162-2531
Container-title:Molecular Therapy - Nucleic Acids
language:en
Short-container-title:Molecular Therapy - Nucleic Acids

Author:

Baron Yvonne,Sens Johanna,Lange Lucas,Nassauer Larissa,Klatt Denise,Hoffmann Dirk,Kleppa Marc-Jens^ORCID,Barbosa Philippe Vollmer^ORCID,Keisker Maximilian,Steinberg Viviane,Suerth Julia D.,Vondran Florian W.R.^ORCID,Meyer Johann,Morgan Michael,Schambach Axel,Galla Melanie^ORCID

Funder

Hannover Medical School

Publisher

Elsevier BV

Subject

Drug Discovery,Molecular Medicine

Reference90 articles.

1. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1;Hacein-Bey-Abina;Science,2003

2. Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy;Cartier;Science,2009

3. Chimeric antigen receptor (CAR) T therapies for the treatment of hematologic malignancies: clinical perspective and significance;Boyiadzis;J. Immunother. Cancer,2018

4. Gene therapy for PIDs: progress, pitfalls and prospects;Mukherjee;Gene,2013

5. Transposons: moving forward from preclinical studies to clinical trials;Tipanee;Hum. Gene Ther.,2017

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the potential of cell-derived vesicles for transient delivery of gene editing payloads;Advanced Drug Delivery Reviews;2024-08

2. Viral and nonviral nanocarriers for in vivo CRISPR-based gene editing;Nano Research;2024-06-20

3. Multi-step engineered adeno-associated virus enables whole-brain mRNA delivery;2024-06-06

4. Virus-like particles derived from bacteriophage MS2 as antigen scaffolds and RNA protective shells;Nanomedicine;2024-04-17

5. Virus-like particles (VLPs): A promising platform for combating against Newcastle disease virus;Vaccine: X;2024-01